FDA Inspection 1028785 — Jonathan S. Berek, MD, MMS
The FDA completed an inspection of Jonathan S. Berek, MD, MMS on Feb 17, 2017 in Stanford, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Stanford, CA (United States)
Additional Details
Clinical Investigator (CI)